Avient Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AVNT research report →
Range $43 – $54
Price Chart
About the company
Avient Corporation, established in 1885 and based in Avon Lake, Ohio, is a global enterprise specializing in advanced material solutions, custom formulation services, and sustainable products. The company, which operated as PolyOne Corporation until its rebranding in June 2020, serves markets across the United States, Canada, Mexico, Europe, South America, and Asia. Its operations are divided into three primary business units: 1.
- CEO
- Ashish K. Khandpur
- IPO
- 1999
- Employees
- 9,000
- HQ
- Avon Lake, OH, US
Get TickerSpark's AI analysis on AVNT
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $4.02B
- P/E
- 23.57
- Fwd P/E
- 14.24
- PEG
- 0.55
- P/S
- 1.21
- P/B
- 1.65
- EV/EBITDA
- 12.04
- Div Yield
- 2.50%
- Gross Margin
- 32.15%
- Op Margin
- 9.70%
- Net Margin
- 5.16%
- ROE
- 7.17%
- ROIC
- 4.66%
Latest fiscal year · YoY change
- Revenue
- $3.26B+0.6%
- Gross Profit
- $1.06B+0.1%
- Op Income
- $203.50M
- Net Income
- $81.90M-51.7%
- EPS
- $0.90-51.6%
- OCF Growth
- +17.4%
- FCF Growth
- +44.6%
- 52W High
- $46.64
- 52W Low
- $27.48
- 50D MA
- $38.50
- 200D MA
- $35.79
- Beta
- 1.28
- RSI (14)
- 60
- Avg Volume
- 908.16K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Avient delivered a strong Q2 with better-than-expected volume growth, record margins, and a raised full-year outlook for EBITDA, EPS, free cash flow, and debt reduction.· August 6, 2026
- Adjusted EPS was $0.96, or $0.09 ahead of expectations, with organic sales up 4.3% and adjusted EBITDA up double digits year over year.
- Q2 adjusted EBITDA margin reached a record 18.3%, up 110 basis points year over year, helped by operating leverage and productivity.
- Asia was a standout, with organic sales up 18% year over year, while packaging, consumer, defense, and building/construction all showed strength.
- Management raised 2026 guidance for adjusted EBITDA to $575 million-$603 million, adjusted EPS to $3.10-$3.25, and free cash flow to $210 million-$230 million.
- The company repaid $50 million of debt in Q2 and now expects year-end net leverage of 2.2x-2.4x.
Avient reported second-quarter adjusted EPS of $0.96, beating expectations by $0.09. Organic sales grew 4.3%, adjusted EBITDA rose double digits year over year, and adjusted EBITDA margin was a record 18.3%, up 110 basis points. On a segment basis, Color, Additives and Inks posted 5% organic sales growth, 9% adjusted EBITDA growth, and $125 million of segment adjusted EBITDA; Specialty Engineered Materials posted 3% organic sales growth, 20% adjusted EBITDA growth, and $76 million of segment adjusted EBITDA. Management raised full-year 2026 guidance to adjusted EBITDA of $575 million-$603 million, adjusted EPS of $3.10-$3.25, and free cash flow of $210 million-$230 million. Capex guidance was lowered to $120 million-$130 million from $140 million, and Q3 adjusted EPS is expected to be approximately $0.80, up 14% year over year.
Ashish Khandpur framed the quarter as evidence that Avient’s strategy is working through customer focus, innovation, pricing discipline, and productivity. He emphasized that much of the improvement came from factors within management’s control rather than a broad macro recovery, and highlighted strong momentum in packaging, consumer, defense, building and construction, and improving demand in energy/telecom. He also pointed to the company’s innovation pipeline, including non-PFAS packaging solutions and Preperm dielectric materials for robotics and autonomous vehicles, as an important growth engine.
Joe Di Salvo highlighted the financial leverage in the quarter, noting that C&AI delivered 5% organic sales growth and 80 basis points of margin expansion to 21.7%, while SEM delivered 3% organic sales growth and 310 basis points of margin expansion to 76 million of adjusted EBITDA. He said Q2 included about 100 basis points of SEM margin benefit from lapping roughly $3 million of planned maintenance expense in Q2 2025, with the rest from mix and productivity. He also said the company repaid $50 million of debt in the quarter, has reduced debt by $200 million over the last 12 months, and expects to repay $100 million-$150 million for the full year, exiting 2026 at net leverage of 2.2x-2.4x.
Analysts focused on the source of upside in Q2, pricing versus volume, and whether there was any prebuying; management said the biggest driver was volume, with roughly one-quarter of organic growth from volume and three-quarters from price, and said they do not believe prebuying was material. Questions also covered SEM margin expansion, where management said the second-half target is about 100 basis points year over year, driven mainly by mix and productivity, plus better defense and electronics mix. On capital allocation, management said that as leverage approaches the 2.2x-2.4x target, debt paydown remains a priority but buybacks and M&A are now options, with nothing imminent.
The call showed broad operational momentum, with 4.3% organic growth, record margins, and sequential improvement across regions, including 20% sequential growth in Asia. Management sounded confident that volume growth will increasingly drive results in the second half, while innovation and share gains support packaging, electronics, and data-center-related opportunities.
Management still sees a volatile demand backdrop, with transportation described as soft and not expected to improve in the second half, and healthcare affected by customer inventory rebalancing. The company also flagged macro uncertainty, inflation, geopolitical risks, and less visibility in Q4, which is why the EPS guidance range remains relatively wide.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 99.3%
- Shares Outstanding
- 91.71M
- Float Shares
- 91.07M
of shares held by institutions
346 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Congressional trading
Senate and House stock disclosures for AVNT, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Gilbert CisnerosHouse · CA31 | Buy | Mar 3, 26 | Filing → |
| Gilbert CisnerosHouse · CA31 | Buy | Sep 2, 25 | Filing → |
| Lisa McClainHouse · MI09 | Buy | Jun 11, 25 | Filing → |
| Thomas R. CarperSenate · DE | Sell | Apr 17, 23 | Filing → |
| Josh GottheimerHouse · NJ05 | Sell | Jun 21, 22 | Filing → |
| Gilbert CisnerosHouse · CA31 | Buy | Jul 30, 20 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Blackrock, Inc. | 11.82M | ▲ 731.44K |
| Vanguard Group Inc | 10.22M | ▲ 77.25K |
| Dimensional Fund Advisors LP | 5.26M | ▲ 287.19K |
| Vanguard Capital Management LLC | 4.12M | ▲ 8.74K |
| State Street Corp | 3.85M | ▲ 284.77K |
| Alliancebernstein L.P. | 3.49M | ▲ 819.99K |
| Wellington Management Group Llp | 3.01M | ▲ 78.94K |
| Geode Capital Management, LLC | 2.51M | ▲ 145.20K |
| Channing Capital Management, LLC | 2.38M | ▲ 345.54K |
| Allspring Global Investments Holdings, LLC | 2.27M | ▼ 707.62K |
| Invesco Ltd. | 1.98M | ▲ 144.81K |
| Jennison Associates LLC | 1.86M | ▲ 453.44K |
Held by 383 ETFs
Biggest fund positions in AVNT by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 30, 26 | WULFSOHN WILLIAM A | other | 1,049 |
| Jun 30, 26 | Verduin Patricia | other | 1,049 |
| Jun 30, 26 | Preete Kerry J | other | 1,049 |
| Jun 30, 26 | Nicolas Ernest | other | 1,049 |
| Jun 30, 26 | Mink Kim Ann | other | 1,049 |
| Jun 30, 26 | Jellison William R | other | 1,049 |
| Jun 30, 26 | Green Neil | other | 1,049 |
| Jun 30, 26 | FEARON RICHARD H | other | 1,049 |
| Jun 30, 26 | LIN SANDRA BEACH | other | 1,049 |
| Jun 30, 26 | ABERNATHY ROBERT E | other | 1,049 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our AVNT coverage
Recent articles, reports, and earnings notes.
No research on AVNT yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AVNT report →4 Diversified Chemical Stocks to Gain Amid Stable End-market Demand
zacks.com · Aug 18
AVNT Q2 Earnings Top Estimates on Organic Growth, Guidance Up
zacks.com · Aug 13
Avient (AVNT) is a Great Momentum Stock: Should You Buy?
zacks.com · Aug 11
4 Best PEG-Driven Value Stocks to Buy Now for Strong Returns
zacks.com · Aug 10
Avient Q2 Earnings Call Highlights
marketbeat.com · Aug 7
Avient Corporation (AVNT) Q2 2026 Earnings Call Transcript
seekingalpha.com · Aug 6
Why Avient (AVNT) is a Great Dividend Stock Right Now
zacks.com · Aug 6
AVNT or AIQUY: Which Is the Better Value Stock Right Now?
zacks.com · Aug 6
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.